The Lymphocytic Infiltrate of Lung Tumors.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorScientific Institute San Raffaele
About this trial
The study is configured as a monocentric observational transversal biological study.
The main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity, in particular non-small cell lung cancer (NSCLC).
The study involves the collection of clinical data and biological material (blood and tumor tissue) from 70 subjects diagnosed with thoracic tumors.
Eligibility criteria
Qualifiers
Ability to provide informed consent;
Men and women over the age of 18;
Patients candidates for surgical treatment diagnosed with thoracic tumors
Disqualifiers
Previous chemotherapy for any cancer within the last 6 months;
Pregnant and/or breastfeeding women;
Immunosuppressive state (states of immunosuppression or ongoing immunosuppressive/immunomodulatory treatments)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1Scientific Institute Ospedale San Raffaele20132, Milan Italy
Sponsors and collaborators
Scientific Institute San Raffaele
Lead sponsor
Source ClinicalTrials.gov